MACHOVA POLAKOVA, Katerina, WALLER, Cornelius und PFIRRMANN, Markus, 2024. The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib. Freiburg: Universität.
Elsevier - Harvard (with titles)Machova Polakova, K., Waller, C., Pfirrmann, M., 2024. The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib. Universität, Freiburg. https://doi.org/10.1038/s41375-023-02109-2
American Psychological Association 7th editionMachova Polakova, K., Waller, C., & Pfirrmann, M. (ca. 2024). The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib [Cd]. Universität. https://doi.org/10.1038/s41375-023-02109-2
Springer - Basic (author-date)Machova Polakova K, Waller C, Pfirrmann M (2024) The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib. Universität, Freiburg
Juristische Zitierweise (Stüber) (Deutsch)Machova Polakova, Katerina/ Waller, Cornelius/ Pfirrmann, Markus, The SNP rs460089 in the gene promoter of the drug transporter OCTN1 has prognostic value for treatment-free remission in chronic myeloid leukemia patients treated with imatinib, Freiburg 2024.